Foundation for Angelman Syndrome Therapeutics Australia

The Foundation for Angelman Syndrome Therapeutics Australia (or FAST) is an organisation dedicated to finding a cure for Angelman Syndrome and related disorders through funding research, education and advocacy. FAST Australia intends to support Australian based research that will function collaboratively with our United States counterparts, aimed at finding a specific treatment for Angelman Syndrome.

FAST Australia is committed to facilitating the establishment of primary investigators in Australia, while maintaining a strong collaborative relationship with AS investigators and the FAST Integrative Research Environment (FIRE) in the United States.

FIRE is a FAST United States initiative dedicated to building a coordinated consortium of leading AS researchers working together to identify, characterise and implement new therapeutics for the treatment and ultimate cure of AS.

FAST Australia operate, and are bound by a constitution that outlines our objectives:

To facilitate research on the prevention, detection and treatment of Angelman Syndrome;
Provide the findings of this research and other information on the Disease to sufferers , carers, the public and medical community;
To engage in activities to raise public awareness of the Disease and particularly the characteristics, diagnosis and treatment of the Disease;
To encourage the commencement of research into the Disease in Australia;
To liaise with other state, national and international organisations associated with research and advocacy; and
To participate in national and international studies and research projects into the Disease.

Funding applications that align with our goals will be reviewed by members of the FAST Scientific Advisory Board.

Interested candidates should contact science@cureangelman.org.au

Australian and United States Researchers at the Inaugural Research Symposium, Melbourne 2013

Our Research

View Australian funded projects, including the University of Sydney Post Doctoral project, RNA binding motifs as therapeutic targets for Angelman Syndrome, here.>

Apply/Enquire about funding for Angelman Syndrome Research